Biomedical Research Center of South China, College of Life Science, Fujian Normal University, Fuzhou 350117, China.
The Key Laboratories of Innate Immune Biology of Fujian Province, Fujian Normal University, Fuzhou 350117, China.
Int J Mol Sci. 2019 Oct 29;20(21):5376. doi: 10.3390/ijms20215376.
Sepsis is defined as "a life-threatening organ dysfunction caused by a host's dysfunctional response to infection". Although the treatment of sepsis has developed rapidly in the past few years, sepsis incidence and mortality in clinical treatment is still climbing. Moreover, because of the diverse manifestations of sepsis, clinicians continue to face severe challenges in the diagnosis, treatment, and management of patients with sepsis. Here, we review the recent development in our understanding regarding the cellular pathogenesis and the target of clinical diagnosis of sepsis, with the goal of enhancing the current understanding of sepsis. The present state of research on targeted therapeutic drugs is also elaborated upon to provide information for the treatment of sepsis.
脓毒症定义为“宿主对感染的反应失调导致的危及生命的器官功能障碍”。尽管近年来脓毒症的治疗有了快速发展,但临床治疗中的脓毒症发病率和死亡率仍在攀升。此外,由于脓毒症表现多样,临床医生在脓毒症患者的诊断、治疗和管理方面仍然面临严峻挑战。在这里,我们回顾了关于脓毒症细胞发病机制和临床诊断靶点的最新研究进展,旨在增强对脓毒症的现有认识。还阐述了针对治疗药物的研究现状,为脓毒症的治疗提供信息。